Affimed Nv share price today

(AFMD)

Affimed Nv share price is $1.19 & ₹101.92 as on 1 Jan 2025, 2.30 'hrs' IST

$1.19

▲

-0.05

(-4.03%)

Market is closed - opens 8 PM, 02 Jan 2025

View live Affimed Nv share price in Dollar and Rupees. Guide to invest in Affimed Nv from India. Also see the sentimental analysis on Indian investors investing in Affimed Nv. Get details on the Indian mutual funds that are investing in Affimed Nv. Get Analyst recommendations and forecasts along with all the Affimed Nv's financials.

Affimed Nv share price movements

Today's Low: $1.19
Today's High: $1.29
$1.19
0.0%
Downside
Day's Volatility :7.75%
Upside
7.75%
52 Weeks Low: $1.14
52 Weeks High: $8.95
$1.19
3.88%
Downside
52 Weeks Volatility :87.22%
Upside
86.7%

Affimed Nv Returns

Period	Affimed Nv	Sector (Health Care)	Index (Russel 2000)
3 Months	-63.5%	-10.0%	0.0%
6 Months	-76.32%	-4.7%	0.0%
1 Year	-79.76%	-0.9%	0.0%
3 Years	-97.89%	-2.4%	-21.2%

Affimed Nv Key Statistics

in dollars & INR

Previous Close	$1.24
Open	$1.24
Today's High	$1.29
Today's Low	$1.19
Market Capitalization	$19.5M
Today's Volume	$302.9K
52 Week High	$8.95
52 Week Low	$1.1438
Revenue TTM	$7.4M
EBITDA	$-71.2M
Earnings Per Share (EPS)	$-4.73
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-124.08%

How to invest in Affimed Nv from India?

It is very easy for Indian residents to invest directly in Affimed Nv from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Affimed Nv stock in both Indian Rupees (INR) and US Dollars (USD). Search for Affimed Nv or AFMD on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Affimed Nv or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Affimed Nv shares which would translate to 0.720 fractional shares of Affimed Nv as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Affimed Nv, in just a few clicks!

Returns in Affimed Nv for Indian investors in Rupees

Investment Value

₹1,00,000

Affimed Nv investment value today

Current value as on today

₹23,105

Returns

₹76,895

(-76.9%)

Returns from Affimed Nv Stock

₹79,762 (-79.76%)

Dollar Returns

₹2,867 (+2.87%)

Indian investors sentiment towards Affimed Nv

71%

Period: Oct 3, 2024 to Jan 1, 2025. Change in 30 Days versus previous period

Search volume for Affimed Nv on INDmoney from India has grown in the last 30 days as on Jan 2, 2025. 71% more investors are searching Affimed Nv in the last 30 days versus the previous period.

Global Institutional Holdings in Affimed Nv

683 Capital Management LLC
3.97%
NEA Management Company, LLC
2.70%
Point72 Asset Management, L.P.
2.09%
Millennium Management LLC
2.08%
Morgan Stanley - Brokerage Accounts
1.36%
Eversept Partners, LLC
1.02%

Analyst Recommendation on Affimed Nv

Buy

85%Buy

14%Hold

0%Sell

Based on 14 Wall street analysts offering stock ratings for Affimed Nv(by analysts ranked 0 to 5 stars)

Based on 14 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Affimed Nv

What analysts predicted

Upside of 1476.0%

Current:

$1.19

Target:

$18.75

Insights on Affimed Nv

Price Movement
In the last 1 month, AFMD stock has moved down by -57.2%
Increasing Revenue
Revenue is up for the last 2 quarters, 154.0K → 155.0K (in $), with an average increase of 0.7% per quarter
Increasing Net Profit
Netprofit is up for the last 8 quarters, -36.73M → -15.13M (in $), with an average increase of 14.1% per quarter
AFMD vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 20.7% return, outperforming this stock by 101.7%
AFMD vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.8% return, outperforming this stock by 136.6%
Price to Sales
ForAFMD every $1 of sales, investors are willing to pay $2.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Affimed Nv Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$27.0M	↑ 1080.85%
Net Income	$-22.2M	↓ 35.56%
Net Profit Margin	-82.06%	↑ 1421.57%

	FY19	Y/Y Change
Revenue	$23.8M	↓ 9.88%
Net Income	$-36.0M	↑ 66.17%
Net Profit Margin	-151.3%	↓ 69.24%

	FY20	Y/Y Change
Revenue	$34.5M	↑ 32.58%
Net Income	$-50.3M	↑ 27.81%
Net Profit Margin	-145.86%	↑ 5.44%

	FY21	Y/Y Change
Revenue	$45.6M	↑ 42.33%
Net Income	$-65.0M	↑ 39.06%
Net Profit Margin	-142.5%	↑ 3.36%

	FY22	Y/Y Change
Revenue	$43.8M	↑ 2.45%
Net Income	$-91.0M	↑ 49.51%
Net Profit Margin	-207.98%	↓ 65.48%

	FY23	Y/Y Change
Revenue	$9.0M	↓ 79.99%
Net Income	$-115.6M	↑ 23.18%
Net Profit Margin	-1.3K%	↓ 1072.24%

	Q2 FY23	Q/Q Change
Revenue	$1.5M	↑ 0.0%
Net Income	$-31.9M	↑ 0.0%
Net Profit Margin	-2.1K%	↑ 0.0%

	Q3 FY23	Q/Q Change
Revenue	$2.1M	↑ 41.15%
Net Income	$-26.0M	↓ 17.15%
Net Profit Margin	-1.2K%	↑ 873.41%

	Q4 FY23	Q/Q Change
Revenue	$169.1K	↓ 92.1%
Net Income	$-20.9M	↓ 21.27%
Net Profit Margin	-12.4K%	↓ 11129.63%

	Q1 FY24	Q/Q Change
Revenue	$154.0K	↓ 0.65%
Net Income	$-15.5M	↓ 19.42%
Net Profit Margin	-10.0K%	↑ 2337.85%

	Q2 FY24	Q/Q Change
Revenue	$154.0K	↑ 0.0%
Net Income	$-15.5M	↑ 0.0%
Net Profit Margin	-10.0K%	↑ 0.0%

	Q3 FY24	Q/Q Change
Revenue	$155.0K	↑ 0.65%
Net Income	$-15.1M	↓ 2.02%
Net Profit Margin	-9.8K%	↑ 266.02%

	FY18	Y/Y Change
Profit	$27.0M	↑ 1080.85%

	FY19	Y/Y Change
Profit	$23.8M	↓ 9.88%

	FY20	Y/Y Change
Profit	$34.5M	↑ 32.58%

	FY21	Y/Y Change
Profit	$45.6M	↑ 42.33%

	FY22	Y/Y Change
Profit	$43.8M	↑ 2.45%

	FY23	Y/Y Change
Profit	$9.0M	↓ 79.99%

	Q2 FY23	Q/Q Change
Profit	$1.5M	↑ 0.0%

	Q3 FY23	Q/Q Change
Profit	$2.1M	↑ 41.15%

	Q4 FY23	Q/Q Change
Profit	$169.1K	↓ 92.1%

	Q1 FY24	Q/Q Change
Profit	$154.0K	↓ 0.65%

	Q3 FY24	Q/Q Change
Profit	$155.0K	-

	FY18	Y/Y Change
Operating Cash Flow	$56.2M	↓ 293.5%
Investing Cash Flow	$-17.8M	↓ 293.91%
Financing Cash Flow	$23.3M	↓ 13.88%

	FY19	Y/Y Change
Operating Cash Flow	$-32.3M	↓ 158.77%
Investing Cash Flow	$4.8M	↓ 127.8%
Financing Cash Flow	$28.9M	↑ 27.05%

	FY20	Y/Y Change
Operating Cash Flow	$-23.6M	↓ 33.23%
Investing Cash Flow	$9.7M	↑ 84.47%
Financing Cash Flow	$84.2M	↑ 165.97%

	FY21	Y/Y Change
Operating Cash Flow	$-97.9M	↑ 346.35%
Investing Cash Flow	$-4.4M	↓ 148.09%
Financing Cash Flow	$151.0M	↑ 92.89%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-36.2M	↑ 0.0%
Investing Cash Flow	$-3.3K	↑ 0.0%
Financing Cash Flow	$-2.8M	↑ 0.0%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-19.5M	↓ 45.24%
Investing Cash Flow	$-40.0M	↑ 1248400.0%
Financing Cash Flow	$-1.7M	↓ 37.6%

Affimed Nv Technicals Summary

Sell

Neutral

Buy

Affimed Nv is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Affimed Nv Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Affimed Nv	-52.21%	-76.32%	-79.76%	-97.89%	-95.28%
Regeneron Pharmaceuticals, Inc.	-4.97%	-31.12%	-22.37%	13.59%	91.62%
Biontech Se	-1.42%	42.28%	3.53%	-50.85%	155.61%
Alnylam Pharmaceuticals, Inc.	-6.56%	-6.26%	23.43%	35.31%	102.91%
Vertex Pharmaceuticals Incorporated	-11.88%	-15.14%	-1.95%	80.96%	79.75%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Affimed Nv	NA	NA	0.0	-3.96	-1.24	-0.49	NA	3.85
Regeneron Pharmaceuticals, Inc.	17.61	17.61	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Affimed Nv	Buy	$19.5M	-95.28%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.3B	91.62%	17.61	33.61%
Biontech Se	Buy	$27.3B	155.61%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.4B	102.91%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$103.7B	79.75%	32.84	-4.51%

About Affimed Nv

affimed (symbol: afmd) is a nasdaq-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies. immuno-oncology represents a highly promising approach to cancer treatment that seeks to harness the body’s own immune defenses to attack and destroy tumor cells. natural killer cells, or nk-cells, and t-cells belong to the most potent cells of the human defense arsenal. affimed’s proprietary, next-generation bispecific antibodies, termed tandabs®, are designed to bring nk-cells or t-cells into close proximity to cancer cells that ultimately triggers a signal cascade that leads to the destruction of cancer cells. due to their novel tetravalent tandem architecture, which provides for four binding domains, the tandabs bind to specific targets on immune and cancer cells with high affinity. in addition, tandabs exhibit kinetic properties allowing the administration as regular intravenous infusion and fine-tuning of dosing. affimed beli

Organization	Affimed Nv
Employees	76
CEO	Dr. Wolfgang Fischer Ph.D.
Industry	Health Technology

Management People of Affimed Nv

Name	Title
Dr. Wolfgang Fischer Ph.D.	MD, COO & Member of Management Board
Ms. Denise Mueller	Chief Business Officer & Member of Management Board
Dr. Andreas Harstrick M.D.	Chief Medical Officer & Member of Management Board
Dr. Shawn M. Leland Pharm.D., R.Ph.	Chief Executive Officer
Prof. Melvyn Little	Founder & Consultant
Mr. Michael Wolf	Head of Finance & Administration
Mr. Alexander Fudukidis	Head of Investor Relations & Director of Investor Relations
Mary Beth Sandin	Vice President of Marketing & Communications

Important FAQs about investing in Affimed Nv from India :

What is Affimed Nv share price today?

Affimed Nv share price today stands at $1.19, Open: $1.24 ; Previous Close: $1.24 ; High: $1.29 ; Low: $1.19 ; 52 Week High: $8.95 ; 52 Week Low: $1.14. The stock opens at $1.24, after a previous close of $1.24. The stock reached a daily high of $1.29 and a low of $1.19, with a 52-week high of $8.95 and a 52-week low of $1.14.

Can Indians buy Affimed Nv shares?

Yes, Indians can invest in the Affimed Nv (AFMD) from India.

With INDmoney, you can buy Affimed Nv at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Affimed Nv at zero transaction cost.

How can I buy Affimed Nv shares from India?

It is very easy to buy Affimed Nv from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Affimed Nv be purchased?

Yes, you can buy fractional shares of Affimed Nv with INDmoney app.

What are the documents required to start investing in Affimed Nv stocks?

To start investing in Affimed Nv, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.